[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:melas-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":52,"states":53},"MELAS Syndrome",6,3,[8,16,23,29,37,44],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06451757","KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases",[12],"Phase 3","RECRUITING","2026-08-26T02:15:52.238965Z","2026-07-05T05:32:16.760200Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05241262","Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels",[20],"Phase 1","2026-08-26T02:18:32.765187Z","2026-05-05T02:43:28.188922Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT01532791","Natural History Study - Mitochondrial Disease",[],"2026-08-26T02:17:21.315591Z","2026-05-13T02:55:06.074185Z",{"nct_id":30,"title":31,"phases":32,"status":34,"updated_at":35,"content_modified":36},"NCT06792500","A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)",[33],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-26T02:17:55.355429Z","2026-05-05T02:43:29.531998Z",{"nct_id":38,"title":39,"phases":40,"status":41,"updated_at":42,"content_modified":43},"NCT01803906","Tissue Sample Study for Mitochondrial Disorders",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:05.997056Z","2026-06-16T05:54:07.946495Z",{"nct_id":45,"title":46,"phases":47,"status":49,"updated_at":50,"content_modified":51},"NCT06961344","An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)",[48],"Phase 2","ACTIVE_NOT_RECRUITING","2026-08-03T03:06:01.435370Z","2026-06-16T05:54:07.844053Z",[],[54],{"state":55,"count":56,"slug":57},"New York",4,"new-york"]